Conference Reports for NATAP
10th International Congress on Drug Therapy in HIV Infection
Glasgow
November 7-11, 2010
Back
 
Activity of Integrase Inhibitor, S/GSK1349572 in Subjects with HIV Exhibiting Raltegravir Resistance: Week 24 Results of VIKING Study (ING112961)